30.08.1983
kristi.huik@ut.ee

Career

Institutions and positions
01.01.2016–25.02.2018   
University of Tartu, Faculty of Medicine, Institute of Biomedicine and Translational Medicine, Research Fellow of Medical Virology and Microbiology (1,00)
01.09.2015–31.12.2015   
University of Tartu, Faculty of Medicine, Department of Microbiology, Research Fellow of Medical Virology and Microbiology (1,00)
01.06.2014–31.08.2015   
University of Tartu, Faculty of Medicine, Department of Microbiology, Research Fellow of Medical Virology (1,00)
01.03.2014–31.05.2014   
University of Tartu, Faculty of Medicine, Department of Microbiology, Junior Research Fellow of Medical Microbiology (1,00)
01.05.2006–31.08.2013   
University of Tartu, Faculty of Medicine, Department of Microbiology, Laboratory Assistant (0,50)
 
 
Education
2002–2007   
Tartu University, Faculty of Medicine, Pharmacy

Qualifications

 
 
Fields of research
ETIS CLASSIFICATION: 3. Health; 3.11. Biochemistry, Genetics, Microbiology, Biotechnology, Molecular Biology, Cell Biology, Biophysics and Bioinformatics relating to Health Studies; SPECIFICATION: Influence of IH-virus tropism, human genetic factors and co-infections on the course of the disease
 
 

Publications

Category
Year
Publication
 
1.1.
2018
1.1.
2018
1.1.
2017
1.1.
2017
1.1.
2016
1.1.
2016
1.1.
2016
1.1.
2016
1.1.
2016
1.1.
2015
1.1.
2015
5.2.
2015
5.2.
2015
5.2.
2015
5.2.
2015
1.1.
2014
1.1.
2014
1.1.
2014
1.1.
2014
5.2.
2014
5.2.
2014
5.2.
2014
5.2.
2014
5.2.
2014
5.2.
2014
5.2.
2014
5.2.
2014
5.2.
2014
1.1.
2013
1.1.
2013
1.1.
2013
5.2.
2013
5.2.
2013
5.2.
2013
5.2.
2013
5.2.
2013
5.2.
2013
1.1.
2012
5.2.
2012
5.2.
2012
5.2.
2012
5.2.
2012
5.2.
2012
5.2.
2012
1.1.
2011
5.2.
2011
1.1.
2010
1.1.
2010
5.2.
2010
1.1.
2009
5.2.
2009
3.5.
2008
5.2.
2008
5.2.
2008
5.2.
2008
5.2.
2008
5.1.
2007
5.1.
2007
18.04.2019
30.08.1983
kristi.huik@ut.ee

Teenistuskäik

Töökohad ja ametid
01.01.2016–25.02.2018   
Tartu Ülikool, Meditsiiniteaduste valdkond, bio- ja siirdemeditsiini instituut, meditsiinilise viroloogia ja mikrobioloogia teadur (1,00)
01.09.2015–31.12.2015   
Tartu Ülikool, Arstiteaduskond, Mikrobioloogia instituut, meditsiinilise viroloogia ja mikrobioloogia teadur (1,00)
01.06.2014–31.08.2015   
Tartu Ülikool, Arstiteaduskond, Mikrobioloogia instituut, meditsiinilise viroloogia teadur (1,00)
01.03.2014–31.05.2014   
Tartu Ülikool, Arstiteaduskond, Mikrobioloogia instituut, meditsiinilise mikrobioloogia nooremteadur (1,00)
01.05.2006–31.08.2013   
Tartu Ülikool, Arstiteaduskond, Mikrobioloogia instituut, laborant (0,50)
 
 
Haridustee
2002–2007   
Tartu Ülikool, Arstiteaduskond, Proviisoriõpe

Kvalifikatsioon

 
 
Teadustöö põhisuunad
ETIS KLASSIFIKAATOR: 3. Terviseuuringud; 3.11. Terviseuuringutega seotud uuringud, näiteks biokeemia, geneetika, mikrobioloogia, biotehnoloogia, molekulaarbioloogia, rakubioloogia, biofüüsika ja bioinformaatika; TÄPSUSTUS: HI-viiruse tropismi, peremeesorganismi geneetiliste fakotite ja ko-infektsioonide mõju haiguse kulule

Lõppenud projektid

Publikatsioonid

Klass
Aasta
Publikatsioon
 
1.1.
2018
1.1.
2018
1.1.
2017
1.1.
2017
1.1.
2016
1.1.
2016
1.1.
2016
1.1.
2016
1.1.
2016
1.1.
2015
1.1.
2015
5.2.
2015
5.2.
2015
5.2.
2015
5.2.
2015
1.1.
2014
1.1.
2014
1.1.
2014
1.1.
2014
5.2.
2014
5.2.
2014
5.2.
2014
5.2.
2014
5.2.
2014
5.2.
2014
5.2.
2014
5.2.
2014
5.2.
2014
1.1.
2013
1.1.
2013
1.1.
2013
5.2.
2013
5.2.
2013
5.2.
2013
5.2.
2013
5.2.
2013
5.2.
2013
1.1.
2012
5.2.
2012
5.2.
2012
5.2.
2012
5.2.
2012
5.2.
2012
5.2.
2012
1.1.
2011
5.2.
2011
1.1.
2010
1.1.
2010
5.2.
2010
1.1.
2009
5.2.
2009
3.5.
2008
5.2.
2008
5.2.
2008
5.2.
2008
5.2.
2008
5.1.
2007
5.1.
2007
18.04.2019
  • Found 9 results
ProgramTypeNumberNameProject startProject endPrincipal investigatorInstitutionFinancing
2.2.1.VMVBS17197RAS testing for their HCV GT1 patients01.03.201731.01.2018Kristi HuikUniversity of Tartu, Faculty of Medicine, Institute of Biomedicine and Translational Medicine287,00 EUR
ETFETF8415Impact of CCR5 and CCL3L1 genetic polymorphism and their expression modulating viruses on the immune activation of antiretrovirus treatment positive HIV-patients.01.01.201031.12.2013Tõnis KarkiUniversity of Tartu, Faculty of Medicine61 354,00 EUR
ETFETF8856The impact of regulatory region methylation of CCR5 and its signaling pathway associated genes on the HIV seropositivity in the caucasian intravenous drug users population01.01.201131.12.2013Silver TürkUniversity of Tartu, Faculty of Medicine25 200,00 EUR
ETFETF7933Emerging resistance of Clostridium difficile strains to antibiotics and disinfectants compared to pheno- and genotypic properties01.01.200931.12.2011Siiri KõljalgUniversity of Tartu, Faculty of Medicine44 175,68 EUR
SFSF0182726s06HIV infection in Estonia: molecular and clinical implications of host and virus interactions.01.01.200631.12.2011Irja LutsarUniversity of Tartu, Faculty of Medicine372 766,67 EUR
SFSF0180004s12Infection and immunocompromised host - from mechanisms to translation into clinical practice01.01.201231.12.2014Irja LutsarUniversity of Tartu, Faculty of Medicine349 080,00 EUR
IUTIUT34-24Management of infections in the immunocompromised host – from bench to bedside01.01.201531.12.2020Irja LutsarUniversity of Tartu, Faculty of Medicine, Institute of Biomedicine and Translational Medicine698 400,00 EUR
ETFETF9259Epidemiology and molecular genetics of pertussis01.01.201231.12.2015Marje OonaUniversity of Tartu, Faculty of Medicine86 217,60 EUR
ETFETF8004Influence of host genetic polymorphisms on evolution of HIV monophyletic population01.01.200931.12.2012Tõnu KrispinUniversity of Tartu, Faculty of Medicine80 989,62 EUR